CollPlant Biotechnologies (CLGN) Free Cash Flow (QoQ) (2018 - 2025)
CollPlant Biotechnologies (CLGN) Free Cash Flow (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.53% |
| Sep 30, 2025 | -18.01% |
| Dec 31, 2024 | -2.93% |
| Sep 30, 2024 | 11.22% |
| Jun 30, 2024 | -17.50% |
| Mar 31, 2024 | -49.86% |
| Dec 31, 2023 | -130.15% |
| Sep 30, 2023 | 306.02% |
| Jun 30, 2023 | -3.09% |
| Mar 31, 2023 | 73.40% |
| Dec 31, 2022 | -331.99% |
| Sep 30, 2022 | 19.51% |
| Jun 30, 2022 | -22.53% |
| Mar 31, 2022 | -193.95% |
| Dec 31, 2021 | 55.15% |
| Sep 30, 2021 | 29.51% |
| Jun 30, 2021 | -127.92% |
| Mar 31, 2021 | 380.04% |
| Dec 31, 2020 | -354.86% |
| Sep 30, 2020 | 198.62% |